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rich in resistant starch, which is used by colonic microbiota for the anaerobic production of the short-
chain fatty acids that serve as a major fuel source for colonocytes: first, green dwarf banana flour
produces protective effects on the intestinal inflammation acting as a prebiotic and, second,
combination of this dietary supplementation with prednisolone presents synergistic effects. For this,
we used the trinitrobenzenesulphonic acid (TNBS) model of rat colitis. Our results revealed that the
protective effect produced by a combination of 10% green dwarf banana flour with prednisolone was
more pronounced than those promoted by a single administration of prednisolone or a diet containing
10% or 20% banana flour. This beneficial effect was associated with an improvement in the colonic
oxidative status because the banana flour diet prevented the glutathione depletion and inhibited
myeloperoxidase activity and lipid peroxidation. In addition, the intestinal anti-inflammatory activity
was associated with an inhibition of alkaline phosphatase activity, a reduction in macroscopic and
microscopic scores, and an extension of the lesions. In conclusion, the dietary use of the green dwarf
banana flour constitutes an important dietary supplement and complementary medicine product to
prevention and treatment of human inflammatory bowel disease.© 2012 Elsevier Inc. Open access under the ElsevKeywords: Banana; Dietary products; Functional foods; Inflammatory bowel disease; Musa sp AAA; Ulcerative colitis;
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Open access under the Elsevier OA license.Crohn disease and ulcerative colitis. Although much
progress has been made in understanding the pathogenesis
of human IBD, its etiology has not yet been defined.
However, accumulating evidence suggests that this
disease results from an inappropriate inflammatory
response to intestinal microbes in a genetically susceptible
host [1]. Furthermore, intestinal microbiota is linked to
IBD pathogenesis because of its role in modulating
Table 1
Ingredient composition of the diets fed to rats (g/100 g)
Ingredients Control
diet
10% Banana
diet
20% Banana
diet
Protein mix 23.0 20.7 18.5
Mineral mix a 12.0 10.8 9.7
Fiber 5.0 4.5 3.6
Vitamin mix b 1.0 0.9 0.8
Fat 10.0 9.0 8.0
Fatty acids 5.5 4.95 4.4
Corn starch 32.0 28.8 25.7
Sugar mix 6.0 5.4 4.9
Soybean meal 2.5 2.25 2.0
Wheat bran 3.0 2.7 2.4
Banana flour c – 10.0 20.0
a Mineral mixture provided the following amounts (in milligrams per
kilogram): Mg, 1.7; Mn, 110.0; I, 1.0; Co, 2.0; Fe, 180.0; Zn, 110.0; Cu,
30.0, Se, 0.2, Na, 2.8, P, 8.5; and Ca, 13.0.
b Vitamin mixture provided the following amounts (in milligrams per
kilogram per diet): vitamin A (25 600 UI); vitamin D3 (4000 UI); vitamin E
(82 mg); vitamin K (6.4 mg); vitamin B12 (40 μg); vitamin B6 (11 mg); folic
acid (13 mg); choline (2800 mg); biotin (0.16 mg); niacin (220 mg);
thiamine (11 mg); and pantothenic acid (90 mg).
c Fruits of green dwarf banana (Musa sp AAA) containing starch
(73.6%-79.4%), amylose (20.9%-23.5%), protein (2.61%-2.99%), soluble
fiber (2.29%-2.49%), insoluble fiber (5.35%-5.39%), ash (3.44%-3.56), and
traces of lipids [16].
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fact, increasing experimental evidence supports the role of
luminal bacteria in the initiation and development of the
intestinal inflammatory process [3,4]. On the basis of
these findings, 2 approaches have been used to modify
intestinal microflora, the administration of probiotics or
prebiotics, which are defined as nondigestible food
ingredients that beneficially affect the host by selectively
stimulating the growth and/or the activity of limited
bacteria in the colon [5].
Dietary fiber, defined as plant substances that resist
hydrolysis by small bowel digestive enzymes, has been
proven to be beneficial in maintaining remission in human
ulcerative colitis, and this protective effect has been
related to an increase in the luminal production of short-
chain fatty acids (SCFAs), which are considered to be an
important factor in the maintenance of healthy function in
colorectal mucosa [6]. In fact, several studies have
reported that some prebiotics including dietary fiber,
germinated barley foodstuff, inulin, lactulose, and poly-
dextrose exert beneficial effects in both human and
experimental colitis models [7,8].
Banana is the fourth most important crop in developing
countries, with a worldwide production of about 100 metric
tons [9]. Fruits of the green dwarf banana (Musa sp AAA) are
rich in starch granules containing 73.6% to 79.4% starch, and
of the total amount of starch (14%), 47.3% to 54.2% is
considered to be resistant starch [10-12]. Resistant starch is a
nondigestible polysaccharide used as a dietary fiber that is
resistant to digestion in the small intestine and used by
colonic microbiota for the anaerobic fermentation production
of SCFA [10-14].
Currently, the pharmacologic treatments for IBD
include corticosteroids, aminosalicylates, immunomodula-
tors, and anti–tumor necrosis factor-α antibodies, but these
pharmacologic therapies result in serious adverse events,
particularly after a long-term use. Because of these
adverse effects and the chronic nature of IBD, there is
dissatisfaction with current traditional therapies, which has
led to an increase in the use of complementary and
alternative medicine approaches including prebiotics and
probiotics. The use of these compounds is currently
estimated to be 49.5% [15,16].
Given that the green dwarf banana (Musa spp AAA) is
an important source of resistant starch with several
physiological effects consistent with those of dietary
fibers and prednisolone, a drug that presents serious
adverse effects from long-term use, two hypothesis of this
study were evaluated. First: dietary supplementation with
green dwarf banana flour produces protective effects on
the intestinal inflammatory process acting as a prebiotic.
Second: combination of dietary supplementation with
prednisolone presents synergistic effects. For this purpose,
we assayed the effects of the green dwarf banana flour and
their combination with prednisolone in preventing the
acute inflammatory response induced by trinitrobenzen-sulphonic acid (TNBS). In this experimental model,
macroscopic, microscopic, and biochemical parameters
were evaluated.2. Methods and materials
2.1. Chemicals
All chemicals were supplied by Sigma (St Louis, Mo) and
were freshly prepared for each animal administration or
biochemical evaluation. The enriched diet with green dwarf
banana flour was manufactured in the School of Medicine,
São Paulo State University, UNESP, São Paulo, Brazil.
2.2. Plant material and diet preparation
Green dwarf banana fruits (Musa spp AAA) were
collected in Botucatu City, São Paulo, Brazil, in December
2010. The plant was identified by taxonomists from Irina
Felanova Gemtchjnicov Herbarium (Institute of Biosciences,
São Paulo State University, UNESP), where a voucher
specimen was deposited.
After collection, the green banana fruits were washed,
chopped, and dried at 50°C for 72 hours in a hothouse with
forced air circulation and renewal. After drying, the dried
fruits were powdered to produce flour. For the preparation of
the enriched diet, the flour was added at a ratio of 10% and
20% in previously sprayed Labina-Purine food for rodents.
After homogenization, water was added to produce a paste.
The paste was then placed in a pelletizer to produce diet
pellets containing 10% or 20% green dwarf banana flour.
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the major nutrients of the normal Labina-Purine, taking into
account the addition of 10% or 20% green dwarf banana
flour (Table 1).
2.3. Animals
Male Wistar rats (weighing 180-200 g) from the Central
Animal House, São Paulo State University–UNESP,
Botucatu, São Paulo, Brazil, were housed in standard
environmental conditions (21°C, 60%-70% humidity)
under a 12-hour light/dark cycle and air filtration. The
animals had free access to water and food (Purina-Labine,
São Paulo, Brazil). All experimental protocols met the
Guidelines of Animal Experimentation approved by the
Commission of Ethics in Animal Experimentation (protocol
number 042/04-CEAE), Institute of Biosciences, São Paulo
State University–UNESP.
2.4. Experimental design
The rats were randomly assigned into 9 groups with
8 animals each. Two of the groups, a noncolitic group and a
colitic group, received no treatment. Two additional
noncolitic groups received an enriched diet with 10% and
20% dwarf banana flour for 21 days. Two colitic groups
received an enriched diet with 10% and 20% dwarf banana
flour for 14 days before colitis induction and 7 days
thereafter. Two additional colitic groups received the
enriched diet in the same conditions listed previously plus
treatment with prednisolone administered at a dosage of
2 mg/kg for 3 days before colitis induction and 7 days
thereafter. For comparison, the remaining group received
only prednisolone (5 mg/kg) for 3 days before colitis
induction and 7 days thereafter. Prednisolone was adminis-
tered by means of an esophageal catheter (5 mL/kg). Rats
from the noncolitic and nontreated colitic groups received
water orally. Colitis was induced using the method originally
described by Morris et al [17]. After fasting overnight, the
animals were anesthetized with halothane. Under anesthesia,
they were given 10 mg of trinitrobenzenesulfonic acid
(TNBS) dissolved in 0.25 mL of 50% (vol/vol) ethanol by
means of a Teflon (Dupont, Wilmington, Del) cannula
inserted 8 cm into the anus. During and after TNBS
administration, the rats were kept in a head-down position
until they recovered from the anesthesia. Rats from the
noncolitic (normal) group received 0.25 mL of saline.
Animals from all groups were euthanized 7 days after colitis
induction by an overdose of halothane.
2.5. Assessment of colonic damage
Animal body weights, the occurrence of diarrhea (as
detected by perianal fur soiling), and total food intake for
each group were recorded daily. Once the rats were killed,
the colon was removed aseptically, placed on an ice-cold
plate, and longitudinally opened. The luminal contents were
then collected for the microbiological studies (see below).Afterward, the colonic segment was cleaned of fat and
mesentery and blotted on a filter paper. Each specimen was
weighed, and its length was measured under a constant load
(2 g). The colon was scored for macroscopically visible
damage on a 0 to 10 scale by 2 observers who were unaware
of the treatment, in accordance with the criteria described by
Bell et al [18].
Representative whole-gut specimens were taken from a
region of the inflamed colon corresponding to the segment
adjacent to the gross macroscopic damage and were fixed in
4% buffered formaldehyde. Cross sections were selected and
embedded in paraffin. Equivalent colonic segments were
also obtained from the noncolitic group. Full-thickness
sections of 5 mm were obtained at different levels and were
stained with hematoxylin and eosin. The histologic damage
was evaluated by one observer who was blind to the
experimental groups, according to the criteria described
previously by Stucchi et al [19]. The colon was subsequently
divided into different longitudinal pieces to be used for the
following biochemical determinations: myeloperoxidase
(MPO) activity, alkaline phosphatase (AP) activity, and
total glutathione (GSH) content.
Myeloperoxidase activity was determined using the
technique described by Krawisz et al [20]. The results are
expressed as MPO units per gram of tissue. One unit of MPO
activity was defined as the amount required to degrade 1
mmol of hydrogen peroxide per minute at 25°C.
Alkaline phosphatase activity was determined spectro-
photometrically using disodium nitrophenylphosphate (5.5
mmol/L) as the substrate buffered in 50 mmol/L glycine with
0.5 mmol/L MgCl2 at pH 10.5 [21]. The enzymatic activity is
expressed as milliunits per milligram of protein [22].
Glutathione content was quantified with the recycling
assay described by Anderson [23], and the results are
expressed as nanomoles per gram of wet tissue.2.6. Antioxidant activity
Additional in vitro experiments were performed to
determine the antioxidant activity of different concentrations
of green dwarf banana flour (1-100 μg/mL). The antioxidant
activity was evaluated using an assay of lipid peroxidation in
rat brain membranes [24] modified from the original protocol
described by Gálvez et al [25]. The flavonoid quercetin was
used as a reference and tested in the same assay system.2.7. Microbiological studies
Luminal content samples were weighed, homogenized,
and serially diluted in sterile 0.85% saline. Serial 10-fold
dilutions of the homogenates were plated on Man, Rogosa,
and Sharpeagar, a specific media for lactic acid bacteria, and
were incubated under microaerobic conditions (5% CO2) at
35°C for 120 hours. After incubation, the final colony count
was reported as log10 colony-forming units per gram of
fecal material.
Table 2
Effects of different treatments on damage score, extension of lesion, changes in colonic weight, incidence of adherence, and microscopic score in acute
TNBS colitis
Experimental groups
(n = 8)
Macroscopic
score a (0-10)
Extension of
lesion (cm) b
Colon weight
(mg/cm)
Adherence c
(%)
Microscopic
score a
Noncolitic groups
Nontreated 0 ⁎⁎⁎ 0 ⁎⁎ 99.39 ± 7.90 ⁎⁎ 0 ⁎⁎ 0 ⁎⁎⁎
10% diet 0 ⁎⁎⁎ 0 ⁎⁎ 102.07 ± 2.64 ⁎⁎ 0 ⁎ 0 ⁎⁎⁎
20% diet 0 ⁎⁎⁎ 0 ⁎⁎ 112.12 ± 8.33 ⁎⁎ 0 ⁎ 0 ⁎⁎⁎
Colitic groups
TNBS control 6.0 (6-10) 2.85 ± 0.76 216.43 ± 32.67 50.0 14.0 (12-17)
10% diet 5.0 (0-6) 1.81 ± 0.76 160.37 ± 22.00 12.5 ⁎ 10.0 (9-11)
20% diet 2.0 (0-4) ⁎ 1.37 ± 0.35 ⁎ 138.30 ± 8.71 ⁎ 12.5 ⁎ 9.5 (8-13) ⁎
10% diet + prednisolone 1.0 (0-5) ⁎ 1.16 ± 0.71 ⁎ 149.59 ± 13.47 ⁎ 12.5 ⁎ 8.0 (7-10) ⁎⁎⁎
20% diet + prednisolone 5.0 (3-6) 3.25 ± 1.01 171.00 ± 11.10 0.0 ⁎ 13.0 (11-13)
Prednisolone 3.0 (0-4) ⁎ 1.41 ± 0.29 ⁎ 162.21 ± 8.14 37.5+ 11.0 (8-14) ⁎
a Score data are expressed as the median (range) and analyzed by Kruskal-Wallis test.
b Extension of lesion and colonic weight data are expressed as the means ± SEM and analyzed by ANOVA followed by post hoc test of Dunnett.
c Adherence is expressed in percentage and analyzed by χ2 test.
∗ P b .05 vs TNBS control group.
∗∗ P b .01 vs TNBS control group.
∗∗∗ P b .001 vs TNBS control group.
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The results are expressed as means ± SEM values, and
differences between the means were tested for statistical
significance using a 1-way analysis of variance (ANOVA)
and post hoc least significance tests. Nonparametric data
(scores) are expressed as the median (range) and were
analyzed with the Kruskal-Wallis test. Differences between
proportions were analyzed with the χ2 test. Statistical
significance was set at P b .05.Table 3
Effects of banana diet supplementation (10% and 20%) and their combined
effects with prednisolone (2 mg/kg) on GSH content, MPO, and AP in TNBS
colitis model
Experimental
groups (n)
GSH MPO AP
Noncolitic groups
Nontreated (8) 2302 ± 86.13 ⁎⁎ 243.66 ± 14.58 ⁎⁎ 4.04 ± 0.64⁎⁎
10% diet (8) 2373 ± 109.15 ⁎⁎ 304.94 ± 14.38 ⁎ 2.27 ± 0.20 ⁎⁎
20% diet (8) 2278 ± 117.27⁎⁎ 223.29 ± 11.69 ⁎ 5.97 ± 0.46 ⁎
Colitic groups
TNBS control
(8)
1679 ± 90.87 754.62 ± 115.70 11.37 ± 2.07
10% diet (8) 2070 ± 121.81 ⁎ 778.27 ± 158.34 9.67 ± 0.88
20% diet (8) 2621 ± 133.89⁎⁎ 299.43 ± 22.40 ⁎ 3.12 ± 0.37 ⁎
10% diet +
prednisolone (8)
2257 ± 72.11 ⁎⁎ 388.87 ± 37.21 ⁎ 3.13 ± 0.33 ⁎⁎
20% diet +
prednisolone (8)
2134 ± 113.84 ⁎ 622.79 ± 177.32 9.14 ± 0.81
Prednisolone (8) 2210 ± 46.45 ⁎⁎ 576.07 ± 71.16 6.77 ± 1.00 ⁎
Data are expressed as means ± SEM. Differences were assessed using
ANOVA, followed by post hoc tests of Dunnett.
∗ P b .05 vs TNBS control group.
∗∗ P b .01 vs TNBS control group.3. Results
Trinitrobenzenesulfonic acid administration resulted in
colonic inflammation, which was demonstrated after 7 days
by severe necrosis of the mucosa, typically extending 2.8 to
4.9 cm along the colon, bowel wall thickening, and
hyperemia (Table 2). This inflammatory process was
associated with an increase in the colonic weight/length
ratio, incidence of the adherence of the colon to adjacent
organs (Table 2), and signs of diarrhea in 100% of the colitic.
A histologic assessment of colonic samples from the TNBS
control group revealed severe transmural disruption of the
normal architecture of the colon, extensive ulceration, and
inflammation involving all the intestinal layers of the colon,
giving a score value of 14.0 (Table 2). Biochemically, the
colonic damage was characterized by a reduction in colonic
GSH levels and an increase in MPO and AP (Table 3)
activities when compared with noncolitic animals.
The treatment of noncolitic animals (healthy rats) with
the diet enriched with 10% and 20% dwarf banana flour for
21 days showed no effects on the clinical, macroscopic,
and microscopic parameters analyzed. The measurements
taken from these animals were similar to those taken from
the noncolitic group that received only vehicle (Table 2).No statistical differences were observed in food consump-
tion or weight gain between the experimental groups that
received the enriched diet and those that received the
normal diet.
Feeding a 20% dwarf banana diet to colitic rats resulted in
a lower colonic damage score, with a significant reduction
in the extension of lesion, the colonic weight/length ratio,
and the incidence of adherence to adjacent organs compared
with the TNBS control group (Table 2). The histologic
studies confirmed this intestinal anti-inflammatory effect
with a lower microscopic damage score of 9.5 (Table 2) and
a pronounced recovery in the colon cytoarchitecture with a
Fig. 1. Photomicrography of colon tissue from different groups: noncolitic (A), TNBS control (B), prednisolone (2 mg/kg) (C), 10% banana flour diet (D), 20%
banana flour diet (E), and 10% banana diet + prednisolone (2 mg/kg) (F). The noncolitic group (A) had normal colon histology, including numerous tubular
glands with goblets cells (arrow). The lumen epithelium was intact with typical morphology. B, TNBS control group showing ulceration (u). The goblets cells
were not frequently in the wall of the gland. Severe inflammation in the mucosa and submucosa was observed, with many lymphocytes in the lamina propria
(arrow). In the prednisolone-treated group (C), we observed a mild ulceration in the mucosa (u) and a reduced number of inflammatory cells (arrow) compared
with the TNBS control group. In the group receiving the 10% banana flour diet (D), no inflammatory cells were detected in the mucosa or submucosa, and normal
colon histology was observed, including tubular glands with goblets cells (arrow). In the group treated with the 20% banana flour diet (E), the presence of
inflammatory cells in the submucosa was still evident (arrow), but the area was small compared with the TNBS control group. In animals treated with a 10%
banana diet + prednisolone (F), we observed a mild ulceration in the mucosa (u) and inflammatory cells in the submucosa (arrow), but this number was, thus,
small compared with the TNBS control group.
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TNBS control group (Fig. 1). The intestinal anti-inflamma-
tory effect was also demonstrated biochemically by the
maintenance of the colonic GSH level (Table 3). The
observed decrease in leukocyte infiltration in our histologic
studies was also demonstrated by the reduction in the MPO
activity (Table 3). Indeed, AP activity was also significantly
reduced in rats treated with a diet enriched with 20% dwarf
banana flour, in contrast with the increase of AP activity that
occurred in the TNBS control group (Table 3).Colitic rats that received the 10% dwarf banana flour diet
showed moderate protective effects on the incidence of colon
adherence and GSH colon content only (Table 3). No
significant effects were observed in the damage score, the
microscopic damage score, the extent of colonic lesions, the
colonic weight/length ratio, or the MPO and AP activities
(Tables 2 and 3).
When colitic rats were treated with a combination of the
enriched diet and prednisolone, protective effects were
observed using 10% dwarf banana flour. The combined
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showed significant effects only in the reduction of the
incidence of colon adherence to adjacent organs and
counteracting the GSH depletion induced by the colonic
inflammatory process (Tables 2 and 3). The combined
treatment using the 10% dwarf banana flour diet and
prednisolone provided a beneficial effect in colitic rats, as
demonstrated by the greater reduction in the macroscopic
damage score values associated with a reduction in the
extent of lesions, the colonic weight/length ratio, adherence
of the colon to adjacent organs, and the microscopic damage
score (Table 2). This protective effect was confirmed by
histologic studies that showed a pronounced recovery of
colon cytoarchitecture accompanied by mild ulceration in
mucosa and a reduction of the inflammatory cells in the
submucosa (Fig. 1). The reduced level of inflammatory cell
migration was also confirmed by a reduction in the MPO
activity (Table 3). In addition, this drug combination was
able to counteract GSH depletion and reduce colon AP
activity (Table 3).
The reference drug used, prednisolone, showed anti-
inflammatory effects, as demonstrated by the reduction in the
macroscopic and microscopic damage scores and the extent
of lesions (Table 2). This protective effect was also
biochemically related to the maintenance of the GSH content
and a reduction of AP activity (Table 3). Prednisolone
showed no effects on the MPO activity, the occurrence of
adhesions between the colon and adjacent organs, or the
colonic weight/length ratio (Tables 2 and 3).
No statistical difference in the lactic acid bacteria count
was found between normal and colitic rats. The enriched diet
with 10% and 20% green dwarf banana flour did not alter
lactic acid bacteria counts in noncolitic or colitic animals
(data not shown).
The in vitro experiments performed show that green
dwarf banana flour exerts a concentration-dependent
inhibitory effect on the lipid peroxidation induced in rat
brain membranes, with an IC50 (50% inhibitory concentra-
tion) value of 67.61 ± 2.35 μg/mL. The corresponding IC50
value of quercetin was 0.41 ± 0.17 μg/mL.4. Discussion
Current pharmacologic treatment of IBD includes anti-
inflammatory drugs (aminosalicylates and corticosteroids),
immunosuppressants, biological agents, antibiotics, and
drugs for symptomatic relief [26], but these pharmacologic
therapies result in unwanted adverse effects, particularly
after long-term use. Glucocorticoids, particularly prednis-
olone, are not a viable long-term solution for IBD
management because they produce adverse effects and
damage body parts and their function from long-term use
[27]. Thus, a combination of products that improve the anti-
inflammatory activity of glucocorticoids would be an
important approach for IBD treatment. The present studywas designed to evaluate novel experimental interventions
using green dwarf banana flour as a potential dietary
product because this plant is rich in resistant starch, a type
of starch that may be applied to the prevention of intestinal
inflammatory diseases [28].
In the first set of experiments, we evaluated the effects of
an enriched diet containing 10% and 20% dwarf banana
flour, and our data demonstrated that the diet containing 20%
banana flour prevented the intestinal inflammatory process
induced by TNBS; whereas the diet containing 10% banana
flour only partially prevented this inflammatory process. The
preventive effect promoted by the 20% banana flour diet was
demonstrated by the significant reduction in the macroscopic
parameters evaluated and confirmed by histologic analysis,
the counteraction of GSH content, and the reduction of the
MPO and AP activities. Glutathione is an important
endogenous antioxidant peptide that is reduced in the course
of the intestinal inflammatory process, and MPO is
considered to be a marker of neutrophil infiltration. The
effects on these biochemical mediators are indicative of
antioxidant and anti-inflammatory activity, respectively.
Although the anti-inflammatory activity of prednisolone
was observed, the prevention of the inflammatory process
after supplementation with the 20% banana flour diet was
more pronounced in all parameters analyzed, particularly for
the damage score (2.0 vs 3.0), the incidence of adherence
(12.5% vs 37.5%), the microscopic damage score (9.5 vs
11.0), GSH content (2621 ± 133.89 vs 2210 ± 46.45), and
AP activity (3.12 ± 0.37 vs 6.77 ± 1.00). The colonic weight/
length ratio and MPO activity were significantly reduced
after treatment with the 20% banana flour diet, but these
effects were not significantly altered after the administration
of prednisolone.
In the second set of experiments, we evaluated the effect
of banana flour supplementation on the intestinal anti-
inflammatory activity of prednisolone to determine whether
banana flour improves the pharmacologic activity of this
glucocorticoid that is currently used in treatment of human
IBD. Our results revealed that the combined use of a 10%
banana flour diet with prednisolone was effective for
preventing the intestinal inflammatory process, as demons
trated by the improvement in the macroscopic, microscopic,
histologic, and biochemical inflammatory parameters evalu
ated. This preventive effect was more pronounced than those
observed after a single administration of prednisolone, the
use of the 10% and 20% banana flour diet alone, or the 20%
banana flour diet combined with prednisolone.
The fruits of the green dwarf banana are rich in starch,
primarily presented as resistant starch [10], which can act as
a substrate yielding high levels of butyrate [28], an SCFA
that improves gastrointestinal health, immune surveillance,
and the growth and differentiation of enterocytes [6,29,30].
Recent studies have shown that after 7 days of supplemen-
tation with resistant starch, chronically inflamed rats had the
same butyrate uptake as rats fed on the basal diet [30]. In
fact, prebiotic foodstuffs derived from resistant starch were
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both clinical and animal studies [28,30]. Green dwarf
banana flour has been chosen as a starch source because of
the high content of resistant starch, whereas banana fruit is
considered to be one of the few sources of this resistant
starch available in an ordinary meal [11,31]. In addition to
the great value of resistant starch as a source of butyrate,
resistant starch 2, a starch type present in green dwarf
bananas, is also rich in amylose, which increases SCFA
production and Bifidobacterium spp and Lactobacillus spp
growth in the gut [32-35]. In our experimental conditions,
the intestinal anti-inflammatory effect of the banana flour
diet was not related to prebiotic properties because no
improvement in bacterial growth and development was
observed. However, the methods used to determine bacterial
growth and development are limited, and new studies are
necessary, particularly using other experimental models of
colitis, such as dextran sulfate sodium, and a more
appropriate and specific culture medium.
The role of the reactive metabolites of oxygen and
nitrogen in the pathophysiology of IBD has been reported
[36]. Although the specific pathways leading to cellular
damage are not completely understood, oxidative stress is a
potential etiologic and/or triggering factor for IBD, and
antioxidant therapy can constitute an interesting approach in
the regulation of this intestinal inflammation condition [37].
In fact, the anti-inflammatory effect of 5-aminosalicylic
derivatives has been partially attributed to their free radical
scavenger and antioxidant properties [36]. In addition, some
herbal therapies have been demonstrated to have the ability
to ameliorate IBD via their antioxidant capacity, reducing
indicators of lipid peroxidation, such as MPO, malondialde-
hyde, and thiobarbituric acid reactive substances, or
improving antioxidant power by increasing GSH, catalase,
and superoxide dismutase [38]. Our study shows that green
dwarf banana flour shows antioxidant activity in vitro,
demonstrated by the inhibition of lipid peroxidation in rat
brain membranes, and in vivo, demonstrated by counter-
acting colonic GSH depletion. The observed effect exerted
by the diet enriched with banana flour in preserving the
colonic mucosa from oxidative insult may be a factor in
diminishing the neutrophil infiltration that occurs in response
to TNBS. Brazilian dwarf banana fruit has been described as
a rich source of several potent and common antioxidant
compounds such as vitamin C, α-carotene, β-carotene, and
lutein [39]. Other studies have reported the antioxidant
activity of bananas (Musa sp AAA), demonstrated by a
decrease in lipid peroxides and an increase in GSH content in
the rat liver [40]. Flavonoids from Musa paradisiaca
produce antiperoxidative activity, as demonstrated by the
reduction of malondialdehyde and hydroperoxides concen-
trations and an increase of the catalase and SOD activities in
the rat liver, kidney, and heart [41,42].
On the basis of our results, we can conclude that diet
supplementation with 20% green dwarf banana flour and the
combination use of a 10% banana flour diet withprednisolone prevents TNBS-induced colonic damage in
rats. This effect may be associated with an improvement in
intestinal oxidative stress probably because of the antioxi-
dant properties of bananas. In addition, the beneficial
properties of the green dwarf banana flour may also be
attributed to the described presence of potent antioxidant
compounds, such as vitamin A, carotenes, and lutein, and
fermentation products, such as resistant starch and amylose,
in this plant. Indeed, the protective effect was not related to
prebiotic properties, given that the green dwarf banana flour
did not produce changes in total content of lactic bacteria.
Indeed, although the combination of the 10% green dwarf
banana flour diet with prednisolone produced better effects
than other tested products, this effect was not synergistic
because no statistical differences among the treated groups
were found. In conclusion, the use of green dwarf banana
flour constituted an important dietary supplement and
complementary medicine product in the prevention and
treatment of human IBD. However, because of the
limitations of this study, further research is necessary to
better understand the intestinal anti-inflammatory properties
of this dietary intervention and its combination with
glucocorticoids using other methods of colitis induction
and the evaluation of additional inflammatory mediators.Acknowledgments
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